Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro

Pharmacology Biochemistry and Behavior

Volumn 92, Issue 4, 2009, Pages 642-648

  Mu, Xin ^a   He, Guorong ^a   Cheng, Yinxia ^a   Li, Xiaoxiu ^a   Xu, Bei ^a   Du, Guanhua ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

6 Hydroxydopamine; Baicalein; Neuroprotective; Parkinson's disease

Indexed keywords

ANTIPARKINSON AGENT; APOMORPHINE; BAICALEIN; NEUROPROTECTIVE AGENT; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NERVE FIBER GROWTH; NEURITE; NEUROPROTECTION; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; TREMOR;

ANIMALS; APOPTOSIS; BRAIN; CELL LINE; CELL SURVIVAL; FLAVANONES; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PC12 CELLS; PHYTOTHERAPY; PLANTS, MEDICINAL; RATS; RATS, SPRAGUE-DAWLEY; SCUTELLARIA BAICALENSIS; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

RATTUS; SCUTELLARIA BAICALENSIS;

EID: 67349270928     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.03.008     Document Type: Article

References (30)

1. Aguiar L.M., Nobre Jr. H.V., Macedo D.S., Oliveira A.A., Freitas R.M., Vasconcelos S.M., et al. Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats. Pharmacol Biochem Behav 84 (2006) 415-419 [PubMed: 16844208]
2. Ahmad M., Saleem S., Ahmad A.S., Yousuf S., Ansari M.A., Khan M.B., et al. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. J Neurochem 93 (2005) 94-104 [PubMed: 15773909]
3. Chang J.W., Wachtel S.R., Young D., and Kang U.J. Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions. Neuroscience 88 (1999) 617-628 [PubMed: 10197780]
4. Das K.P., Freudenrich T.M., and Mundy W.R. Assessment of PC12 cell differentiation and neurite growth: a comparison of morphological and neurochemical measures. Neurotoxicol Teratol 26 (2004) 397-406 [PubMed: 15113601]
5. Deumens R., Blokland A., and Prickaerts J. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175 (2002) 303-317 [PubMed: 12061862]
6. Greene L.A., and Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73 (1976) 2424-2428 [PubMed: 1065897]
7. Hsieh C.J., Hall K., Ha T., Li C., Krishnaswamy G., and Chi D.S. Baicalein inhibits IL-1beta- and TNF-alpha-induced inflammatory cytokine production from human mast cells via regulation of the NF-kappaB pathway. Clin Mol Allergy 5 (2007) 5 [PubMed: 18039391]
8. Hwang Y.S., Shin C.Y., Huh Y., and Ryu J.H. Hwangryun-Hae-Dok-tang (Huanglian-Jie-Du-Tang) extract and its constituents reduce ischemia-reperfusion brain injury and neutrophil infiltration in rats. Life Sci 71 (2002) 2105-2117 [PubMed: 12204769]
9. Ikeda Y., Tsuji S., Satoh A., Ishikura M., Shirasawa T., and Shimizu T. Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells. J Neurochem 107 (2008) 1730-1740 [PubMed: 19014378]
10. Jha N., Kumar M.J., Boonplueang R., and Anderson J.K. Glutathione decreases in dopaminergic PC12 cells interfere with the ubiquitin protein degradation pathway: relevance for Parkinson's disease?. J Neurochem 80 (2002) 555-561 [PubMed: 11841562]
11. Kobayashi H., Oikawa S., Umemura S., Hirosawa I., and Kawanishi S. Mechanism of metal-mediated DNA damage and apoptosis induced by 6-hydroxydopamine in neuroblastoma SH-SY5Y cells. Free Radic Res 42 (2008) 651-660 [PubMed: 18654880]
12. Koprich J.B., Reske-Nielsen C., Mithal P., and Isacson O. Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease. J Neuroinflammation 5 (2008) 8 [PubMed: 18304357]
13. Kumar R., Agarwal A.K., and Seth P.K. Free radical-generated neurotoxicity of 6-hydroxydopamine. J Neurochem 64 (1995) 1703-1707 [PubMed: 7891098]
14. Lebeau A., Esclaire F., Rostene W., and Pelaprat D. Baicalein protects cortical neurons from beta-amyloid (25-35) induced toxicity. Neuroreport 12 (2001) 2199-2202 [PubMed: 11447334]
15. Lee H.H., Yang L.L., Wang C.C., Hu S.Y., Chang S.F., and Lee Y.H. Differential effects of natural polyphenols on neuronal survival in primary cultured central neurons against glutamate- and glucose deprivation-induced neuronal death. Brain Res 986 (2003) 103-113 [PubMed: 12965234]
16. Mandel S., and Youdim M.B. Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic Biol Med 37 (2004) 304-317 [PubMed: 15223064]
17. Metz G.A., and Whishaw I.Q. Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance. Neuroscience 111 (2002) 325-336 [PubMed: 11983318]
18. Metz G.A., Farr T., Ballermann M., and Whishaw I.Q. Chronic levodopa therapy does not improve skilled reach accuracy or reach range on a pasta matrix reaching task in 6-OHDA dopamine-depleted (hemi-Parkinson analogue) rats. Eur J Neurosci 14 (2001) 27-37 [PubMed: 11488946]
19. Olanow C.W., and Tatton W.G. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22 (1999) 123-144 [PubMed: 10202534]
20. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. New York: Academic Press; 1986.
21. Perumal A.S., Gopal V.B., Tordzro W.K., Cooper T.B., and Cadet J.L. Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain. Brain Res Bull 29 (1992) 699-701 [PubMed: 1422867]
22. Ridet J.L., Malhotra S.K., Privat A., and Gage F.H. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 20 (1997) 570-577 [PubMed: 9416670]
23. Schober A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res 318 (2004) 215-224 [PubMed: 15503155]
24. Sharma V., Mishra M., Ghosh S., Tewari R., Basu A., Seth P., et al. Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection. Brain Res Bull 73 (2007) 55-63 [PubMed: 17499637]
25. Ungerstedt U., and Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 24 (1970) 485-493 [PubMed: 5494536]
26. van Leyen K., Kim H.Y., Lee S.R., Jin G., Arai K., and Lo E.H. Baicalein and 12/15-lipoxygenase in the ischemic brain. Stroke 37 (2006) 3014-3018 [PubMed: 17053180]
27. Wang S.Y., Wang H.H., Chi C.W., Chen C.F., and Liao J.F. Effects of baicalein on beta-amyloid peptide-(25-35)-induced amnesia in mice. Eur J Pharmacol 506 (2004) 55-61 [PubMed: 15588624]
28. Zafar K.S., Siddiqui A., Sayeed I., Ahmad M., Saleem S., and Islam F. Protective effect of adenosine in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences. J Chem Neuroanat 26 (2003) 143-151 [PubMed: 14599664]
29. Zafar K.S., Siddiqui A., Sayeed I., Ahmad M., Salim S., and Islam F. Dose-dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences. J Neurochem 84 (2003) 438-446 [PubMed: 12558963]
30. Zweig R.M., Singh A., Cardillo J.E., and Langston J.W. The familial occurrence of Parkinson's disease. Lack of evidence for maternal inheritance. Arch Neurol 49 (1992) 1205-1207 [PubMed: 1288529]